<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<QualityMeasureDocument xmlns="urn:hl7-org:v3" xmlns:cql-ext="urn:hhs-cql:hqmf-n1-extensions:v1"
                        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">

      <!--
            **************************************************************
            Measure Details Section
            **************************************************************
        -->

      <typeId extension="POQM_HD000001UV02" root="2.16.840.1.113883.1.3"/>
   <templateId>
      <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.1.2"/>
   </templateId>
   <id root="2c928082-7c31-8117-017c-802fdfa4179c"/>
   <code code="57024-2" codeSystem="2.16.840.1.113883.6.1">
      <displayName value="Health Quality Measure Document"/>
   </code>
   <title value="Discharged on Antithrombotic Therapy"/>
   <text
         value="Ischemic stroke patients prescribed or continuing to take antithrombotic therapy at hospital discharge"/>
   <statusCode code="COMPLETED"/>
   <setId root="42bf391f-38a3-4c0f-9ece-dcd47e9609d9"/>
   <versionNumber value="11.0.000"/>
   <author>
      <responsibleParty classCode="ASSIGNED">
         <representedResponsibleOrganization classCode="ORG" determinerCode="INSTANCE">
            <id>
               <item root="1.3.6.1.4.1.33895"/>
            </id>
            <name>
               <item>
                  <part value="The Joint Commission"/>
               </item>
            </name>
         </representedResponsibleOrganization>
      </responsibleParty>
   </author>
   <custodian>
      <responsibleParty classCode="ASSIGNED">
         <representedResponsibleOrganization classCode="ORG" determinerCode="INSTANCE">
            <id>
               <item root="5"/>
            </id>
            <name>
               <item>
                  <part value="The Joint Commission"/>
               </item>
            </name>
         </representedResponsibleOrganization>
      </responsibleParty>
   </custodian>
   <!--Payer-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.114222.4.11.3591"/>
         <title value="Payer"/>
      </valueSet>
   </definition>
   <!--Non-Elective Inpatient Encounter-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.424"/>
         <title value="Non-Elective Inpatient Encounter"/>
      </valueSet>
   </definition>
   <!--ONC Administrative Sex-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113762.1.4.1"/>
         <title value="ONC Administrative Sex"/>
      </valueSet>
   </definition>
   <!--Ethnicity-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.114222.4.11.837"/>
         <title value="Ethnicity"/>
      </valueSet>
   </definition>
   <!--Comfort Measures-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="1.3.6.1.4.1.33895.1.3.0.45"/>
         <title value="Comfort Measures"/>
      </valueSet>
   </definition>
   <!--Observation Services-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113762.1.4.1111.143"/>
         <title value="Observation Services"/>
      </valueSet>
   </definition>
   <!--Race-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.114222.4.11.836"/>
         <title value="Race"/>
      </valueSet>
   </definition>
   <!--Emergency Department Visit-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.292"/>
         <title value="Emergency Department Visit"/>
      </valueSet>
   </definition>
   <!--Pharmacological Contraindications For Antithrombotic Therapy-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113762.1.4.1110.52"/>
         <title value="Pharmacological Contraindications For Antithrombotic Therapy"/>
      </valueSet>
   </definition>
   <!--Antithrombotic Therapy-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113762.1.4.1110.62"/>
         <title value="Antithrombotic Therapy"/>
      </valueSet>
   </definition>
   <!--Hemorrhagic Stroke-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.212"/>
         <title value="Hemorrhagic Stroke"/>
      </valueSet>
   </definition>
   <!--Medical Reason-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.473"/>
         <title value="Medical Reason"/>
      </valueSet>
   </definition>
   <!--Left Against Medical Advice-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.308"/>
         <title value="Left Against Medical Advice"/>
      </valueSet>
   </definition>
   <!--Ischemic Stroke-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.247"/>
         <title value="Ischemic Stroke"/>
      </valueSet>
   </definition>
   <!--Discharged to Health Care Facility for Hospice Care-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.207"/>
         <title value="Discharged to Health Care Facility for Hospice Care"/>
      </valueSet>
   </definition>
   <!--Patient Expired-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.309"/>
         <title value="Patient Expired"/>
      </valueSet>
   </definition>
   <!--Patient Refusal-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.93"/>
         <title value="Patient Refusal"/>
      </valueSet>
   </definition>
   <!--Discharged to Home for Hospice Care-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.209"/>
         <title value="Discharged to Home for Hospice Care"/>
      </valueSet>
   </definition>
   <!--Discharge To Acute Care Facility-->
     	 <definition>
      <valueSet classCode="OBS" moodCode="DEF">
         <id root="2.16.840.1.113883.3.117.1.7.1.87"/>
         <title value="Discharge To Acute Care Facility"/>
      </valueSet>
   </definition>
   <relatedDocument typeCode="COMP">
      <expressionDocument>
         <id root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
         <text mediaType="text/cql">
            <reference value="https://emeasuretool.cms.gov/libraries/42bf391f-38a3-4c0f-9ece-dcd47e9609d9/CMS104-v11-0-000-QDM-5-6.cql"/>
            <translation mediaType="application/elm+xml">
               <reference value="https://emeasuretool.cms.gov/libraries/42bf391f-38a3-4c0f-9ece-dcd47e9609d9/CMS104-v11-0-000-QDM-5-6.xml"/>
            </translation>
            <translation mediaType="application/elm+json">
               <reference value="https://emeasuretool.cms.gov/libraries/42bf391f-38a3-4c0f-9ece-dcd47e9609d9/CMS104-v11-0-000-QDM-5-6.json"/>
            </translation>
         </text>
         <setId extension="42bf391f-38a3-4c0f-9ece-dcd47e9609d9"
                identifierName="DischargedonAntithromboticTherapy"
                root="https://emeasuretool.cms.gov/libraries"/>
         <versionNumber value="11.0.000"/>
      </expressionDocument>
   </relatedDocument>
   <relatedDocument typeCode="COMP">
      <expressionDocument>
         <id root="2c9280857b2aeb52017b5f8b96c31ff8"/>
         <text mediaType="text/cql">
            <reference value="https://emeasuretool.cms.gov/libraries/8bdc0a19-b210-4a58-8a07-f5d95a34eca9/MATGlobalCommonFunctions-v7-0-000-QDM-5-6.cql"/>
            <translation mediaType="application/elm+xml">
               <reference value="https://emeasuretool.cms.gov/libraries/8bdc0a19-b210-4a58-8a07-f5d95a34eca9/MATGlobalCommonFunctions-v7-0-000-QDM-5-6.xml"/>
            </translation>
            <translation mediaType="application/elm+json">
               <reference value="https://emeasuretool.cms.gov/libraries/8bdc0a19-b210-4a58-8a07-f5d95a34eca9/MATGlobalCommonFunctions-v7-0-000-QDM-5-6.json"/>
            </translation>
         </text>
         <setId extension="8bdc0a19-b210-4a58-8a07-f5d95a34eca9"
                identifierName="MATGlobalCommonFunctions"
                root="https://emeasuretool.cms.gov/libraries"/>
         <versionNumber value="7.0.000"/>
      </expressionDocument>
   </relatedDocument>
   <relatedDocument typeCode="COMP">
      <expressionDocument>
         <id root="2c9280827eb12de9017f31539f1431c6"/>
         <text mediaType="text/cql">
            <reference value="https://emeasuretool.cms.gov/libraries/d838ba65-b0cf-4494-a10f-8e4565b85137/TJCOverall-v6-0-000-QDM-5-6.cql"/>
            <translation mediaType="application/elm+xml">
               <reference value="https://emeasuretool.cms.gov/libraries/d838ba65-b0cf-4494-a10f-8e4565b85137/TJCOverall-v6-0-000-QDM-5-6.xml"/>
            </translation>
            <translation mediaType="application/elm+json">
               <reference value="https://emeasuretool.cms.gov/libraries/d838ba65-b0cf-4494-a10f-8e4565b85137/TJCOverall-v6-0-000-QDM-5-6.json"/>
            </translation>
         </text>
         <setId extension="d838ba65-b0cf-4494-a10f-8e4565b85137" identifierName="TJCOverall"
                root="https://emeasuretool.cms.gov/libraries"/>
         <versionNumber value="6.0.000"/>
      </expressionDocument>
   </relatedDocument>
   <controlVariable>
      <measurePeriod>
         <id extension="measureperiod" root="44db7f27-dbca-4f72-8a19-67ec953609a2"/>
         <code code="MSRTP" codeSystem="2.16.840.1.113883.5.4">
            <originalText value="Measurement Period"/>
         </code>
         <value xsi:type="PIVL_TS">
            <phase highClosed="true" lowClosed="true">
               <low value="20220101"/>
               <width unit="a" value="1" xsi:type="PQ"/>
            </phase>
            <period unit="a" value="1"/>
         </value>
      </measurePeriod>
   </controlVariable>
   <subjectOf>
      <measureAttribute>
         <code nullFlavor="OTH">
            <originalText value="eCQM Identifier (Measure Authoring Tool)"/>
         </code>
         <value mediaType="text/plain" value="104" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code nullFlavor="OTH">
            <originalText value="NQF Number"/>
         </code>
         <value mediaType="text/plain" value="Not Applicable" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="COPY" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Copyright"/>
         </code>
         <value mediaType="text/plain"
                value="Measure specifications are in the Public Domain.&#xA;&#xA;LOINC(R) copyright 2004-2021 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2021 International Health Terminology Standards Development Organisation. ICD-10 copyright 2021 World Health Organization. All Rights Reserved."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="DISC" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Disclaimer"/>
         </code>
         <value mediaType="text/plain"
                value="These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="MSRSCORE" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Measure Scoring"/>
         </code>
         <value code="PROPOR" codeSystem="2.16.840.1.113883.5.1063" xsi:type="CD">
            <displayName value="Proportion"/>
         </value>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="MSRTYPE" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Measure Type"/>
         </code>
         <value code="PROCESS" codeSystem="2.16.840.1.113883.5.1063" xsi:type="CD">
            <displayName value="PROCESS"/>
         </value>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="STRAT" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Stratification"/>
         </code>
         <value mediaType="text/plain" value="None" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="MSRADJ" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Risk Adjustment"/>
         </code>
         <value mediaType="text/plain" value="None" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="MSRAGG" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Rate Aggregation"/>
         </code>
         <value mediaType="text/plain" value="None" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="RAT" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Rationale"/>
         </code>
         <value mediaType="text/plain"
                value="The effectiveness of antithrombotic agents in reducing stroke mortality, stroke-related morbidity and recurrence rates has been studied in several large clinical trials. While the use of these agents for patients with acute ischemic stroke and transient ischemic attacks continues to be the subject of study, substantial evidence is available from completed studies. Data at this time suggest that antithrombotic therapy should be prescribed at discharge following acute ischemic stroke to reduce stroke mortality and morbidity as long as no contraindications exist.&#xA;&#xA;For patients with a stroke due to a cardioembolic source (e.g. atrial fibrillation, mechanical heart valve), warfarin is recommended unless contraindicated. In recent years, novel oral anticoagulant agents (NOACs) have been developed and approved by the U.S. Food and Drug Administration (FDA) for stroke prevention, and may be considered as an alternative to warfarin for select patients. Anticoagulation therapy is not generally recommended for secondary stroke prevention in patients presumed to have a non-cardioembolic stroke.&#xA;Anticoagulants at doses to prevent venous thromboembolism are insufficient antithrombotic therapy to prevent recurrent ischemic stroke or transient ischemic attack (TIA)."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="CRS" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Clinical Recommendation Statement"/>
         </code>
         <value mediaType="text/plain"
                value="Clinical trial results suggest that antithrombotic therapy should be prescribed at discharge following acute ischemic stroke to reduce stroke mortality and morbidity as long as no contraindications exist"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="IDUR" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Improvement Notation"/>
         </code>
         <value mediaType="text/plain" value="Improvement noted as an increase in rate"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONAdams, H., Adams, R., del Zoppo, G., et al. (2005, April). Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update—A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke, 36(4): 916-923."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONAdams, H. P., Jr., del Zoppo, G., Alberts, M. J., et al. (2007, May). Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke, 38(5), 1655-1711."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONAlbers, G. W, Amarenco, P., Easton, J. D., et al. (2001). Antithrombotic and thrombolytic therapy for ischemic stroke. Chest, 119, 300-320."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONAlbers, G. W., Amarenco, P., Easton, J. D., et al. (2004, September). Antithrombotic and thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126(3), 483S-512S."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONAntiplatelet Trialists’ Collaboration. (1994, January 8). Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ, 308(6921), 81-106."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONAntithrombotic Trialists’ Collaboration. (2002, January 12). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ, 324(7329), 71-86."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONBhatt, D. L., Fox, K. A., Hacke, W., et al. (2006, April 20). Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. New England Journal of Medicine, 354(16), 1706-1717."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONBrott, T. G., Clark, W. M., Fagan, S. C., et al. (2000). Stroke: The first hours. Guidelines for acute treatment. Washington, DC: National Stroke Association."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONCanadian Cooperative Study Group. (1978, July 13). A randomized trial of aspirin and sulfinpyrazone in threatened stroke. New England Journal of Medicine, 299(2), 53-59."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONCAPRIE Steering Committee. (1996, November 16). A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348(9038), 1329-1339."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONCenters for Disease Control and Prevention. (2009, May 1). Prevalence and most common causes of disability among adults—United States, 2005. Morbidity and Mortality Weekly Report, 58(16),  421-426."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONChen, Z. M., Sandercock, P., Pan, H. C., et al. (2000, June). Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke, 31(6), 1240-1249."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONCoull, B. M., Williams, L. S., Goldstein, L. B., et al. (2002, July). Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association). Stroke, 33(7), 1934-1942."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONDiener, H. C., Bogousslavsky, J., Brass, L. M., et al. (2004, July). Aspirin and lopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial. Lancet, 364(9431), 331-337."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONDutch Tia Trial Study Group. (1991, October 31). A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. New England Journal of Medicine, 325(18), 1261-1266."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONEccles, M., Freemantle, N., &amp; Mason, J. (1998, April 25). North of England Evidence-Based Guideline Development Project: Guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. BMJ, 316(7140), 1303-1309."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONESPRIT Study Group, Halkes, P. H., van Gijn, J., et al. (2006, May 20). Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet, 367(9523), 1665-1673."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONESPS Group. (1987, December 12). The European Stroke Prevention Study (ESPS): Principal end-points. Lancet, 2(8572), 1351-1354."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONFarrell, B., Godwin, J., Richards, S., et al. (1991, December). The United Kingdom Transient Ischaemic Attack (Uk-Tia) Aspirin Trial: Final results. Journal of Neurology, Neurosurgery, and Psychiatry, 54(12), 1044-1054."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONGaspoz, J. M., Coxson, P. G., Goldman, P. A., et al. (2002, June 6). Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. New England Journal of Medicine, 346(23), 1800-1806."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONGent, M., Blakely, J. A., Easton, J. D., et al. (1989, June 3). The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1(8649), 1215-1220."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONGorelick, P. B., Richardson, D., Kelly, M., et al. (2003, June 11). Aspirin and ticlopidine for prevention of recurrent stroke in black patients: A randomized trial. JAMA, 289(22), 2947-2957."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONGuyatt, G. H., Akl, E. A., Crowther, M., et al. (2012, February). Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141(2 Suppl.), 7S-47S."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONGuyatt, G., Schunemann, H., Cook, D., et al. (2001, January). Grades of recommendation for antithrombotic agents. Chest, 119(1 Suppl.), 3S-7S."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONHass, W. K., Easton, J. D., Adams, H. P., Jr., et al. (1989, August 24). Randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New England Journal of Medicine, 321(8), 501-507."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONInternational Stroke Trial Collaborative Group. (1997, May 31). The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet, 349(9065), 1569-1581."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONJauch, E. C., Saver, J. L., Adams, H. P., Jr., et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870-947."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONJohnson, E. S., Lanes, S. F., Wentworth, C. E., III, et al. (1999, June 14). A metaregression analysis of the dose-response effect of aspirin on stroke. Archives of Internal Medicine, 159(11), 1248-1253."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONKennedy, J., Hill, M. D., Ryckborst, K. J., et al. (2007, November). Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurology, 6(11): 961-969."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONKernan, W. N., Ovbiagele, B., Black, H. R., et al. (2014, May). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 45(7), 2160-2223."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONKleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., ... Williams, L. S. (2021). 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/American Stroke Association. Stroke, 52(7), e364-e467. https://doi.org/10.1161/STR.0000000000000375"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONPowers, W. J., Rabinstein, A. A., Ackerson, T., et al. (2018, January). 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for health care professionals from the American Heart Association/American Stroke Association. Stroke, 49, e45-e46."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONRoger, V. L., Go, A. S., Lloyd-Jones, D. M., et al. (2012, January 3). Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation, 125(1), e2-e220."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONSacco, R. L., Diener, H. C., Yusuf, S., et al. (2008, September 18). Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. New England Journal of Medicine, 359(12), 1238-1251."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONSALT Collaborative Group. (1991, November 30). Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet, 338(8779), 1345-1349."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="REF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Reference"/>
         </code>
         <value mediaType="text/plain"
                value="CITATIONUK-Tia Study Group. (1988, January 30). United Kingdom Transient Ischaemic Attack (UK-Tia) Aspirin Trial: Interim results. British Medical Journal (Clinical Research Ed.), 296(6618), 316-320."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="DEF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Definition"/>
         </code>
         <value mediaType="text/plain" value="None" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="GUIDE" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Guidance"/>
         </code>
         <value mediaType="text/plain"
                value="The &quot;Non-elective Inpatient Encounter&quot; value set intends to capture all non-scheduled hospitalizations. This value set is a subset of the &quot;Inpatient encounter&quot; value set, excluding concepts that specifically refer to elective hospital admissions. Non-elective admissions include emergency, urgent and unplanned admissions.&#xA;&#xA;The &quot;Medication, Discharge&quot; datatype refers to the discharge medication list and is intended to express medications ordered for post-discharge use.&#xA;&#xA;The denominator population includes patients with inpatient hospitalizations and patients from Acute Hospital Care at Home programs, who are treated and billed as inpatients but receive care in their home.&#xA;&#xA;This eCQM is an episode-based measure. An episode is defined as each inpatient hospitalization or encounter that ends during the measurement period.&#xA;&#xA;This version of the eCQM uses QDM version 5.6. Please refer to the eCQI resource center (https://ecqi.healthit.gov/qdm) for more information on the QDM."
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="TRANF" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Transmission Format"/>
         </code>
         <value mediaType="text/plain" value="TBD" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="IPOP" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Initial Population"/>
         </code>
         <value mediaType="text/plain"
                value="Inpatient hospitalizations for patients age 18 and older, discharged from inpatient care (non-elective admissions) with a principal diagnosis of ischemic or hemorrhagic stroke and a length of stay less than or equal to 120 days that ends during the measurement period"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="DENOM" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Denominator"/>
         </code>
         <value mediaType="text/plain"
                value="Inpatient hospitalizations for patients with a principal diagnosis of Ischemic stroke"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="DENEX" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Denominator Exclusions"/>
         </code>
         <value mediaType="text/plain"
                value="* Inpatient hospitalizations for patients admitted for elective carotid intervention. This exclusion is implicitly modeled by only including non-elective hospitalizations.&#xA;* Inpatient hospitalizations for patients discharged to another hospital&#xA;* Inpatient hospitalizations for patients who left against medical advice&#xA;* Inpatient hospitalizations for patients who expired&#xA;* Inpatient hospitalizations for patients discharged to home for hospice care&#xA;* Inpatient hospitalizations for patients discharged to a health care facility for hospice care&#xA;* Inpatient hospitalizations for patients with comfort measures documented"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="NUMER" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Numerator"/>
         </code>
         <value mediaType="text/plain"
                value="Inpatient hospitalizations for patients prescribed or continuing to take antithrombotic therapy at hospital discharge"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="NUMEX" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Numerator Exclusions"/>
         </code>
         <value mediaType="text/plain" value="Not Applicable" xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="DENEXCEP" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Denominator Exceptions"/>
         </code>
         <value mediaType="text/plain"
                value="* Inpatient hospitalizations for patients with a documented reason for not prescribing antithrombotic therapy at discharge&#xA;* Inpatient hospitalizations for patients who receive Prasugrel as an antithrombotic therapy at discharge"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <subjectOf>
      <measureAttribute>
         <code code="SDE" codeSystem="2.16.840.1.113883.5.4">
            <displayName value="Supplemental Data Elements"/>
         </code>
         <value mediaType="text/plain"
                value="For every patient evaluated by this measure also identify payer, race, ethnicity and sex"
                xsi:type="ED"/>
      </measureAttribute>
   </subjectOf>
   <componentOf>
      <qualityMeasureSet classCode="ACT">
         <id root="42bf391f-38a3-4c0f-9ece-dcd47e9609d9"/>
         <title value="eMeasure Stroke (eSTK)"/>
      </qualityMeasureSet>
   </componentOf>
   <!--Data Criteria Section-->
   <component>
      <dataCriteriaSection>
         <templateId>
            <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.2.6"/>
         </templateId>
         <code code="57025-9" codeSystem="2.16.840.1.113883.6.1"/>
         <title value="Data Criteria Section"/>
         <text/>
         <entry typeCode="DRIV">
            <localVariableName value="Payer_PatientCharacteristicPayer_Txxfw"/>
            <observationCriteria classCode="OBS" moodCode="EVN">
               <templateId>
                  <item extension="2017-05-01" root="2.16.840.1.113883.10.20.28.4.58"/>
               </templateId>
               <id extension="Payer_PatientCharacteristicPayer"
                   root="34b2381a-4513-4bc4-896b-04a8d30cbea3"/>
               <code code="48768-6" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC">
                  <displayName value="Payer"/>
               </code>
               <title value="Patient Characteristic Payer"/>
               <statusCode code="COMPLETED"/>
               <value valueSet="2.16.840.1.114222.4.11.3591" xsi:type="CD"/>
            </observationCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="Non-ElectiveInpatientEncounter_EncounterPerformed_DJF0d"/>
            <encounterCriteria classCode="ENC" moodCode="EVN">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.5"/>
               </templateId>
               <id extension="Non-ElectiveInpatientEncounter_EncounterPerformed"
                   root="f31f4e2b-6cb3-4ed7-bf7e-197bf6453c3f"/>
               <code valueSet="2.16.840.1.113883.3.117.1.7.1.424"/>
               <title value="Encounter, Performed"/>
               <statusCode code="COMPLETED"/>
            </encounterCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="ONCAdministrativeSex_PatientCharacteristicSex_h7YBT"/>
            <observationCriteria classCode="OBS" moodCode="EVN">
               <templateId>
                  <item extension="2017-05-01" root="2.16.840.1.113883.10.20.28.4.55"/>
               </templateId>
               <id extension="ONCAdministrativeSex_PatientCharacteristicSex"
                   root="810fad44-1b3c-497e-979f-5acdd41350e9"/>
               <code code="263495000" codeSystem="2.16.840.1.113883.6.96" codeSystemName="SNOMED CT">
                  <displayName value="Gender"/>
               </code>
               <title value="Patient Characteristic Sex"/>
               <statusCode code="COMPLETED"/>
               <value valueSet="2.16.840.1.113762.1.4.1" xsi:type="CD"/>
            </observationCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="Ethnicity_PatientCharacteristicEthnicity_QLikF"/>
            <observationCriteria classCode="OBS" moodCode="EVN">
               <templateId>
                  <item extension="2017-05-01" root="2.16.840.1.113883.10.20.28.4.56"/>
               </templateId>
               <id extension="Ethnicity_PatientCharacteristicEthnicity"
                   root="e93597fb-b8f3-4186-8dcc-211706147205"/>
               <code code="54133-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC">
                  <displayName value="Ethnicity"/>
               </code>
               <title value="Patient Characteristic Ethnicity"/>
               <statusCode code="COMPLETED"/>
               <value valueSet="2.16.840.1.114222.4.11.837" xsi:type="CD"/>
            </observationCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="ComfortMeasures_InterventionOrder_nxRjf"/>
            <actCriteria classCode="ACT" moodCode="RQO">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.35"/>
               </templateId>
               <id extension="ComfortMeasures_InterventionOrder"
                   root="3637ec90-b43f-409c-81b3-26b19aed477f"/>
               <code valueSet="1.3.6.1.4.1.33895.1.3.0.45"/>
               <title value="Intervention, Order"/>
               <statusCode code="ACTIVE"/>
            </actCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="ComfortMeasures_InterventionPerformed_JXZZg"/>
            <actCriteria classCode="ACT" moodCode="EVN">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.36"/>
               </templateId>
               <id extension="ComfortMeasures_InterventionPerformed"
                   root="3637ec90-b43f-409c-81b3-26b19aed477f"/>
               <code valueSet="1.3.6.1.4.1.33895.1.3.0.45"/>
               <title value="Intervention, Performed"/>
               <statusCode code="COMPLETED"/>
            </actCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="ObservationServices_EncounterPerformed_d4wpt"/>
            <encounterCriteria classCode="ENC" moodCode="EVN">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.5"/>
               </templateId>
               <id extension="ObservationServices_EncounterPerformed"
                   root="215b8958-753d-4e97-88e4-80e69c50bd14"/>
               <code valueSet="2.16.840.1.113762.1.4.1111.143"/>
               <title value="Encounter, Performed"/>
               <statusCode code="COMPLETED"/>
            </encounterCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="Race_PatientCharacteristicRace_A9fGJ"/>
            <observationCriteria classCode="OBS" moodCode="EVN">
               <templateId>
                  <item extension="2017-05-01" root="2.16.840.1.113883.10.20.28.4.59"/>
               </templateId>
               <id extension="Race_PatientCharacteristicRace"
                   root="9da52dfc-0add-49c3-a5cd-b329722b15fe"/>
               <code code="32624-9" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC">
                  <displayName value="Race"/>
               </code>
               <title value="Patient Characteristic Race"/>
               <statusCode code="COMPLETED"/>
               <value valueSet="2.16.840.1.114222.4.11.836" xsi:type="CD"/>
            </observationCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="EmergencyDepartmentVisit_EncounterPerformed_s1tAv"/>
            <encounterCriteria classCode="ENC" moodCode="EVN">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.5"/>
               </templateId>
               <id extension="EmergencyDepartmentVisit_EncounterPerformed"
                   root="943fd468-a486-47eb-bcef-69bbc31a73a0"/>
               <code valueSet="2.16.840.1.113883.3.117.1.7.1.292"/>
               <title value="Encounter, Performed"/>
               <statusCode code="COMPLETED"/>
            </encounterCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="PharmacologicalContraindicationsForAntithromboticTherapy_MedicationDischarge_x9lc9"/>
            <substanceAdministrationCriteria classCode="SBADM" moodCode="RQO">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.48"/>
               </templateId>
               <id extension="PharmacologicalContraindicationsForAntithromboticTherapy_MedicationDischarge"
                   root="a010f7cd-a967-4df8-a6c6-53386c3a58be"/>
               <code code="10183-2" codeSystem="2.16.840.1.113883.6.1"/>
               <title value="Medication, Discharge"/>
               <statusCode code="ACTIVE"/>
			            <participation typeCode="CSM">
                  <role classCode="MANU">
                     <playingManufacturedMaterial classCode="MMAT" determinerCode="KIND">
                        <code valueSet="2.16.840.1.113762.1.4.1110.52"/>
                     </playingManufacturedMaterial>
                  </role>
               </participation>
		          </substanceAdministrationCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="AntithromboticTherapy_MedicationDischarge_eCsUs"/>
            <substanceAdministrationCriteria classCode="SBADM" moodCode="RQO">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.48"/>
               </templateId>
               <id extension="AntithromboticTherapy_MedicationDischarge"
                   root="7ead6f45-9ec3-4ac8-b5f3-d103c946d978"/>
               <code code="10183-2" codeSystem="2.16.840.1.113883.6.1"/>
               <title value="Medication, Discharge"/>
               <statusCode code="ACTIVE"/>
			            <participation typeCode="CSM">
                  <role classCode="MANU">
                     <playingManufacturedMaterial classCode="MMAT" determinerCode="KIND">
                        <code valueSet="2.16.840.1.113762.1.4.1110.62"/>
                     </playingManufacturedMaterial>
                  </role>
               </participation>
		          </substanceAdministrationCriteria>
         </entry>
         <entry typeCode="DRIV">
            <localVariableName value="AntithromboticTherapy_MedicationNotDischarged_cGptV"/>
            <substanceAdministrationCriteria actionNegationInd="TRUE" classCode="SBADM" moodCode="RQO">
               <templateId>
                  <item extension="2021-02-01" root="2.16.840.1.113883.10.20.28.4.48"/>
               </templateId>
               <id extension="AntithromboticTherapy_MedicationNotDischarged"
                   root="7ead6f45-9ec3-4ac8-b5f3-d103c946d978"/>
               <code code="10183-2" codeSystem="2.16.840.1.113883.6.1"/>
               <title value="Medication, Not Discharged"/>
               <statusCode code="ACTIVE"/>
			            <participation typeCode="CSM">
                  <role classCode="MANU">
                     <playingManufacturedMaterial classCode="MMAT" determinerCode="KIND">
                        <code valueSet="2.16.840.1.113762.1.4.1110.62"/>
                     </playingManufacturedMaterial>
                  </role>
               </participation>
		          </substanceAdministrationCriteria>
         </entry>
      </dataCriteriaSection>
   </component>
   <component>
      <populationCriteriaSection>
         <templateId>
            <item extension="2017-08-01" root="2.16.840.1.113883.10.20.28.2.7"/>
         </templateId>
         <id extension="PopulationCriteria1" root="444D86C6-026A-4561-8421-63FC79B32738"/>
         <code code="57026-7" codeSystem="2.16.840.1.113883.6.1"/>
         <title value="Population Criteria Section"/>
         <text/>
         <component typeCode="COMP">
            <initialPopulationCriteria classCode="OBS" moodCode="EVN">
               <id extension="initialPopulation" root="E91EDC55-495A-4218-B937-72326A0C82E6"/>
               <code code="IPOP" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;Initial Population&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </initialPopulationCriteria>
         </component>
         <component typeCode="COMP">
            <denominatorCriteria classCode="OBS" moodCode="EVN">
               <id extension="denominator" root="41898230-5801-4596-BA66-354450EDBE66"/>
               <code code="DENOM" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;Denominator&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </denominatorCriteria>
         </component>
         <component typeCode="COMP">
            <denominatorExclusionCriteria classCode="OBS" moodCode="EVN">
               <id extension="denominatorExclusions" root="2455D8E8-5F3C-4458-9563-4BBAED159AFD"/>
               <code code="DENEX" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;Denominator Exclusions&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </denominatorExclusionCriteria>
         </component>
         <component typeCode="COMP">
            <denominatorExceptionCriteria classCode="OBS" moodCode="EVN">
               <id extension="denominatorExceptions" root="CCF76BC4-B523-473B-91CB-8BF9956BAF90"/>
               <code code="DENEXCEP" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;Denominator Exceptions&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </denominatorExceptionCriteria>
         </component>
         <component typeCode="COMP">
            <numeratorCriteria classCode="OBS" moodCode="EVN">
               <id extension="numerator" root="61D9BB19-14C0-4018-B075-283FB648EC0E"/>
               <code code="NUMER" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;Numerator&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </numeratorCriteria>
         </component>
         <component typeCode="COMP">
            <cql-ext:supplementalDataElement>
               <id extension="Supplemental Data Elements"
                   root="2F622CB1-0820-49AC-82F0-92E18D236ABB"/>
               <code code="SDE" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;SDE Ethnicity&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </cql-ext:supplementalDataElement>
         </component>
         <component typeCode="COMP">
            <cql-ext:supplementalDataElement>
               <id extension="Supplemental Data Elements"
                   root="19DEAC9E-BF9A-484E-BA28-71BA66474A91"/>
               <code code="SDE" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;SDE Payer&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </cql-ext:supplementalDataElement>
         </component>
         <component typeCode="COMP">
            <cql-ext:supplementalDataElement>
               <id extension="Supplemental Data Elements"
                   root="E7513FBD-225A-4067-89E7-342FC1CBCDCC"/>
               <code code="SDE" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;SDE Race&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </cql-ext:supplementalDataElement>
         </component>
         <component typeCode="COMP">
            <cql-ext:supplementalDataElement>
               <id extension="Supplemental Data Elements"
                   root="EA573A30-A8CA-4D15-861C-5C76AD45A210"/>
               <code code="SDE" codeSystem="2.16.840.1.113883.5.4" codeSystemName="Act Code"/>
               <precondition typeCode="PRCN">
                  <criteriaReference classCode="OBS" moodCode="EVN">
                     <id extension="DischargedonAntithromboticTherapy.&quot;SDE Sex&quot;"
                         root="97ABFEC6-2907-46E5-987F-D9F326D696A4"/>
                  </criteriaReference>
               </precondition>
            </cql-ext:supplementalDataElement>
         </component>
      </populationCriteriaSection>
   </component>
</QualityMeasureDocument>